Publication | Closed Access

Eosinophil-derived neurotoxin as a biomarker for disease severity and relapse in recalcitrant atopic dermatitis

InflammationAllergyAtopic DermatitisRecalcitrant Atopic DermatitisDisease SeverityImmunologySkin AllergyAutoimmunityEosinophil-derived NeurotoxinEosinophilic DisorderDermatologyMedicineHypersensitivity